Payers, providers, patients – even politicians – attacking Gilead over $1,000/day hepatitis C pill

Featured Story

Payers, providers, patients – even politicians – attacking Gilead over $1,000/day hepatitis C pill

April 13, 2014 8:19 am by | 2 Comments

The nation may have finally met a drug it cannot afford.
Sovaldi is a long-awaited breakthrough for the 3 million Americans suffering from the hepatitis C virus. And at $1,000 a daily pill, or $84,000 over 12 weeks of treatment, the medication could ge…


J&J income rises 35 percent in first quarter

J&J income rises 35 percent in first quarter

April 15, 2014 11:07 am by | 0 Comments

Johnson & Johnson’s net income rose 35 percent during the first quarter thanks in part to stronger sales in its pharmaceutical division, the company said Tuesday. The New Brunswick-based health…


Zohydro ban: Disagreeing with Governor Patrick

Zohydro ban: Disagreeing with Governor Patrick

April 15, 2014 8:01 am by | 1 Comments

Massachusetts Governor Deval Patrick is trying to ban Zohydro ER, a new prescription painkiller, under a state of emergency he’s declared to combat opiate abuse. I agree with the Governor…



Provectus Biopharmaceuticals signs with Chinese firm to find licensing partner

Provectus Biopharmaceuticals signs with Chinese firm to find licensing partner

April 15, 2014 6:45 am by | 0 Comments

Knoxville-based Provectus Biopharmaceuticals has signed with an investment banking firm in China to help identify distribution and joint venture partners for the company’s oncology drug PV-10. Shanghai-based Tririver Capital Co.,…


Glenmark receives $5 million milestone payment from Sanofi

Glenmark receives $5 million milestone payment from Sanofi

April 15, 2014 3:53 am by | 0 Comments

MUMBAI — Drug maker Glenmark Pharmaceuticals Ltd said on Tuesday that its new drug candidate for the treatment of autoimmune disorder has achieved another milestone towards final stage of discovery….


Scripps, Johnson & Johnson join forces in drug development effort

Scripps, Johnson & Johnson join forces in drug development effort

April 14, 2014 10:46 am by | 0 Comments

JUPITER — In an effort to spur start-up biotech companies, Scripps Florida said Monday that it has created a new venture and has partnered with a big-name drug firm. The…


High cost of potent Hepatitis drug presents challenges across the U.S.

High cost of potent Hepatitis drug presents challenges across the U.S.

April 14, 2014 9:39 am by | 0 Comments

Sovaldi, the hepatitis C treatment drug, is considered a breakthrough for patients with the disease. However, since, it won federal approval in December, lawmakers, insurers and patient advocates have begun…


Independent pharmacy hoping to carve niche over big box stores

Independent pharmacy hoping to carve niche over big box stores

April 13, 2014 9:03 am by | 0 Comments

Miss. — A customer looking to fill a prescription doesn’t have to look hard these days. The nation’s largest pharmacies, Walgreens and CVS, battle for prime locations; big-box retailers like…



‘Molecular tweezers:’ A potential new strategy for fending off Alzheimer’s?

‘Molecular tweezers:’ A potential new strategy for fending off Alzheimer’s?

April 11, 2014 5:52 am by | 0 Comments

Rather than trying to break up clumps of proteins that characterize many brain diseases including Parkinson’s and Alzheimer’s disease, Gal Bitan and his team are trying to stop them from…


GPhA calls for US-EU convergence in biosimilar and generic medicine regulation

GPhA calls for US-EU convergence in biosimilar and generic medicine regulation

April 10, 2014 10:48 pm by | 0 Comments

By James C. Shehan – The Generic Pharmaceuticals Association (“GPhA”) opened a new front in its ongoing battle to shape the approval process for biosimilars, while also calling for more…


UW spinout is hoping a drug could stave off hearing loss caused by antibiotics

UW spinout is hoping a drug could stave off hearing loss caused by antibiotics

April 9, 2014 4:05 pm by | 0 Comments

University of Washington spinout Oricula Therapeutics said today it’s secured funding and intellectual property that will allow it to move forward with developing a way to prevent hearing loss associated…


Spero Therapeutics catches Roche’s eye with a new way to target drug-resistant bacterial infections

Spero Therapeutics catches Roche’s eye with a new way to target drug-resistant bacterial infections

April 9, 2014 11:42 am by | 0 Comments

Overcoming challenges posed by the growing number of infections that are resistant to traditional antibiotics is the goal of a startup surfacing today with a $3 million Series A and…


AbbVie plans production facility in Saudi Arabia

AbbVie plans production facility in Saudi Arabia

April 8, 2014 7:22 pm by | 0 Comments

JEDDAH — AbbVie has announced its launch in Saudi Arabia as an independent biopharmaceutical company after separation from Abbott Laboratories.
The event was attended by Abboud Bejjani, vice president of AbbVie in the Middle East and Rami Fayed, Gener…


To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data

April 8, 2014 7:00 am by | 1 Comments

Big Pharma spends billions of dollars each year researching, developing and testing new treatments for cancer. In the meantime, it’s also collecting millions of data points that figuratively sit on…


GlaxoSmithKline launches probe into claims of misconduct in Iraq

GlaxoSmithKline launches probe into claims of misconduct in Iraq

April 7, 2014 3:45 pm by | 0 Comments

British drug-maker GlaxoSmithKline said it is launching an investigation into claims of misconduct in Iraq. The announcement comes months after China began looking into allegations of a bribery ring within…


Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion

Irish firm to buy fast-growing MS-drug maker Questcor for $5.6 billion

April 7, 2014 1:13 pm by | 0 Comments

Irish pharmaceutical company Mallinckrodt will pay $5.6 billion in cash and stock for Anaheim-based Questcor Pharmaceuticals Inc., a fast-growing bio-pharmaceutical firm that specializes in treating multiple sclerosis, the companies announced…